Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NervGen Pharma Corp
NGENF
Primary Symbol:
V.NGEN
Healthcare
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a...
therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:NGEN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 27, 2023 10:40am
Volume going gangbusters, as well as the price
Market has been open for less than an hour and already 82,000 shares traded, 10,000 in just the last 5 minutes. Price already up 6% from yesterday's closing which was a new high for the year
...more
(16)
•••
stargazer1
X
View Profile
View Bullboard History
Post by
stargazer1
on Dec 26, 2023 4:12pm
Moving up PARABOLICALLY. LOOK AT THE CHART + NEWS RELEASES
No press release for almost two months, but their press releases have been VERY POSITIVE. Prior to their tenacious research and pharmacuetical examination, NO ONE HAD ANY WAY OF REVERSING SPINAL, OR
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(13)
•••
austrochris
X
View Profile
View Bullboard History
Post by
austrochris
on Aug 09, 2023 2:46am
NervGen Pharma: A “Blockbuster Drug” in the Making ?!
Even Biogen will be jealous
(13)
•••
austrochris
X
View Profile
View Bullboard History
Post by
austrochris
on Aug 08, 2023 1:06pm
just great news
NervGen Pharma to Proceed with Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury Having Completed FDA Review and Received IRB Approval @newsfile/nervgen-pharma-to-proceed-with
...more
(0)
•••
WALLSTREEETHERO
X
View Profile
View Bullboard History
Comment by
WALLSTREEETHERO
on Jun 28, 2023 10:55am
RE:This has 1,000 bagger potential, article coming next week
https://finance.yahoo.com/news/nervgen-pharma-receive-more-us-123000753.html
(0)
•••
WALLSTREEETHERO
X
View Profile
View Bullboard History
Comment by
WALLSTREEETHERO
on Jun 28, 2023 10:55am
RE:NervGen Pharma’s NVG-291-R Demonstrates Significant Function
https://finance.yahoo.com/news/nervgen-pharma-receive-more-us-123000753.html
(0)
•••
WALLSTREEETHERO
X
View Profile
View Bullboard History
Comment by
WALLSTREEETHERO
on Jun 28, 2023 10:54am
RE:NervGen Pharma’s NVG-291-R Demonstrates Significant Function
lets go.......
(42)
•••
greenland
X
View Profile
View Bullboard History
Post by
greenland
on Sep 28, 2022 10:19am
Biogen Explodes Higher After Potential Mega Blockbuster Alzh
Biogen Explodes Higher After Potential Mega Blockbuster Alzheimer's Drug Succeeds (yahoo.com)
(13)
•••
curious924
X
View Profile
View Bullboard History
Post by
curious924
on Jul 28, 2022 3:05pm
Incredible news! Unbelievable that this board is not going
I agree with the assessment from the last news release. Best stock out there, but apparently little known. The stock is up nearly 25% and one post about it? Market cap is under $85 million Cnd.
...more
(42)
•••
greenland
X
View Profile
View Bullboard History
Post by
greenland
on Jul 28, 2022 12:23pm
NervGen Pharma’s NVG-291-R Demonstrates Significant Function
NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
...more
(20)
•••
Geodan2
X
View Profile
View Bullboard History
Comment by
Geodan2
on May 05, 2022 1:32pm
RE:NervGen Article is out today, link below
No one is here. Best stock have ever found and it is that way because people do not know about it. https://ceo.ca/ article is on front page of CEO now. One reason NervGen has not
...more
(20)
•••
Geodan2
X
View Profile
View Bullboard History
Post by
Geodan2
on May 04, 2022 4:05pm
NervGen Article is out today, link below
Article published https://ceo.ca/@geodan/nervgen-regenerates-neurons-what-is-a-drug-that-reverses-paralysis-ms-stroke-and-alzheimers-worth NervGen Regenerates Neurons, What Is A Drug That Reverses
...more
(20)
•••
Geodan2
X
View Profile
View Bullboard History
Post by
Geodan2
on Apr 29, 2022 3:43pm
This has 1,000 bagger potential, article coming next week
NervGen Regenerates Neurons, What Is A Drug That Reverses Paralysis, MS, Stroke And Alzheimer's Worth? Apr. 23, 2022 7:17 PM ET| About: NervGen Pharma Corp. (NGENF), Includes: KRRGF, PTRUF
...more
(42)
•••
greenland
X
View Profile
View Bullboard History
Post by
greenland
on Mar 15, 2022 10:52am
Finally some news!
NervGen Pharma (TSXV:NGEN) receives approval to advance clinical trial of NVG-291 – The Market Herald
(2)
•••
Napaildog
X
View Profile
View Bullboard History
Post by
Napaildog
on Oct 23, 2021 3:54pm
Great update on this zoom link for ngen
Zoom link: us02web.zoom.us/j/83730654372
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >